Please wait...
Abbott’s mission is to invent breakthrough technologies that transform the treatment of some of the world’s most expensive epidemic diseases.
Abbott partners with physicians, hospitals, payers and our communities to save and improve millions of lives worldwide—while reducing health care costs for all.
Abbott’s products include sustaining and pioneering technologies that save lives and reduce the economic burden to patients and health care systems.
In today’s complex health care environment, offering outstanding products is no longer enough. Abbott’s customers need comprehensive solutions that help them manage patients throughout the continuum of care. That is why Abbott focuses on innovation, developing first-of-their-kind products and integrated product portfolios that enhance the patient experience and improve outcomes while reducing costs.
Dorsal root ganglion (DRG) therapy is a non-opiod therapy designed to manage difficult-to-treat chronic pain in specific areas of the lower body, such as the foot, knee, or groin. Pain in those areas is sometimes related to a cluster of nerves called the dorsal root ganglia (DRG). If you’re managing pain in those areas, Proclaim™ DRG Neurostimulator System can provide proven therapy to aid in treatment of chronic pain.
The Proclaim™ Elite Recharge-Free SCS System delivers spinal cord stimulation (SCS) that improves patients’ ability to perform everyday activities. With a recharge-free generator and familiar Apple‡ mobile digital devices, the Proclaim™ Elite Recharge-Free SCS System is designed to help you manage your chronic pain as seamlessly as possible.
The Prodigy MRI™ SCS System delivers effective pain relief through spinal cord stimulation (SCS) using Abbott’s smallest implantable pulse generator (IPG). It’s small, discreet and available with Abbott’s proprietary BurstDR™ stimulation, a new technology that’s clinically proven to provide better pain relief than traditional neurostimulation.
